Aarey Drugs & Pharmaceuticals has informed that the Committee of the Board (the Committee) of the Company at its meeting held today has approved the opening of the Issue of today, i.e., on March 12, 2018; approved and adopted the preliminary placement document dated March 09, 2018, in connection with the Issue, (the ‘Preliminary Placement Document’); approved and taken on record the floor price in respect of the Issue, based on the pricing formula as prescribed under Regulation 85 of the SEBI ICDR Regulations being Rs 54.93 per Equity Share; and approved and taken on record, the relevant date for the above purpose, in terms of Regulation 81(c)(i) of the SEBI ICDR Regulations, which is March 12, 2018.
The above information is a part of company’s filings submitted to BSE.
